Literature DB >> 33650166

A prospective study on surgical management of foot deformities in Charcot Marie tooth disease.

Gita Ramdharry1, Dishan Singh2, Julia Gray2, Damian Kozyra1, Mariola Skorupinska1, Mary M Reilly1, Matilde Laurá1.   

Abstract

Foot deformities are frequently observed in patients with Charcot Marie tooth disease (CMT) and orthopaedic surgery is often required. Currently there is no evidence-based guideline on surgical management and only a few studies which have evaluated long-term outcomes of surgical procedures. The aim of the study was to evaluate longitudinally the effect of foot surgery in a cohort of CMT patients. Twenty-five CMT adult patients were assessed using a comprehensive group of validated scales and questionnaires before and after surgery. A wide range of surgical procedures was performed by one team of dedicated foot ankle orthopaedic surgeons. Foot alignment as measured by the foot posture index, pain, quality of life and callosities significantly improved after one year and the improvement was maintained up to 4 years after surgery. There was a trend towards a reduction in the number of falls post-operatively. Surgery had no effect on fatigue, balance and CMT examination score. Our findings showed significant improvement of pain, foot alignment, callosities and quality of life after surgery and suggested that foot deformity correction in adults with CMT performed in a specialised foot and ankle unit is beneficial.
© 2021 Peripheral Nerve Society.

Entities:  

Keywords:  Charcot Marie tooth disease; foot and ankle surgery

Mesh:

Year:  2021        PMID: 33650166     DOI: 10.1111/jns.12437

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  1 in total

1.  Foot Assessment Clinical Scales in Charcot-Marie-Tooth Patients: A Scoping Review.

Authors:  Chiara Rambelli; Davide Mazzoli; Martina Galletti; Giacomo Basini; Paolo Zerbinati; Paolo Prati; Francesca Mascioli; Stefano Masiero; Andrea Merlo
Journal:  Front Hum Neurosci       Date:  2022-06-24       Impact factor: 3.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.